Showing 1-20 of 41 articles
Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves
February 20, 2020 | 10.4244/EIJ-D-19-00710
Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon
January 17, 2020 | 10.4244/EIJV15I13A208
Peripheral interventions
Incidence and predictors of stent thrombosis after endovascular revascularisation of the superficial femoral artery December 20, 2019 | 10.4244/EIJ-D-19-00187
Coronary interventions
Enhanced platelet inhibition by clopidogrel and risk of bleeding in patients requiring oral anticoagulation after drug-eluting stent implantation October 18, 2019 | 10.4244/EIJ-D-18-00995
Coronary interventions
Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial October 1, 2019 | 10.4244/EIJ-D-19-00488
Coronary interventions
Sex and long-term outcomes after implantation of the Absorb bioresorbable vascular scaffold for treatment of coronary artery disease September 20, 2019 | 10.4244/EIJ-D-18-00603
Omission of aspirin after ACS or stenting in patients with oral anticoagulation – why have the goalposts moved?
April 5, 2019 | 10.4244/EIJV14I18A312
No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms
June 20, 2018 | 10.4244/EIJV14I2A21
Coronary interventions
Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials June 20, 2018 | 10.4244/EIJ-D-18-00024
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary
January 19, 2018 | 10.4244/EIJ20170912-01
Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI)
October 20, 2017 | 10.4244/EIJ-D-16-01036
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis
October 20, 2017 | 10.4244/EIJ-D-16-00939
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials
October 20, 2017 | 10.4244/EIJ-D-16-00871
Coronary interventions
State of the art: coronary artery stents – past, present and future August 25, 2017 | 10.4244/EIJ-D-17-00557
Peripheral interventions
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis July 20, 2017 | 10.4244/EIJ-D-16-00735
Interventions for hypertension
Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease June 2, 2017 | 10.4244/EIJ-D-16-00697
Coronary interventions
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique April 20, 2017 | 10.4244/EIJ-D-16-00226
Coronary interventions
Don’t think twice: BMS is never nice January 20, 2017 | 10.4244/EIJV12I13A258